1. Microbiology and Infectious Disease

ODELAM Rapid sequence-independent detection of drug resistance in isolates of Mycobacterium tuberculosis

  1. Thurston Herricks
  2. Magdalena Donczew  Is a corresponding author
  3. Fred D Mast
  4. Tige Rustad
  5. Robert Morrison
  6. Timothy R Sterling
  7. David R Sherman  Is a corresponding author
  8. John D Aitchison  Is a corresponding author
  1. Seattle Children's Research Institute, United States
  2. University of Washington, United States
  3. Vanderbilt University, United States
https://doi.org/10.7554/eLife.56613
Share this article
Cite this article
  1. Thurston Herricks
  2. Magdalena Donczew
  3. Fred D Mast
  4. Tige Rustad
  5. Robert Morrison
  6. Timothy R Sterling
  7. David R Sherman
  8. John D Aitchison
(2020)
ODELAM Rapid sequence-independent detection of drug resistance in isolates of Mycobacterium tuberculosis
eLife 9:e56613.
https://doi.org/10.7554/eLife.56613
  2. Download BibTeX
  3. Download .RIS

Abstract

Antimicrobial-resistant Mycobacterium tuberculosis (Mtb) causes over 200,000 deaths each year. Current assays of antimicrobial resistance need knowledge of mutations that confer drug resistance, or long periods of culture time to test growth under drug pressure. We present ODELAM (One-cell Doubling Evaluation of Living Arrays of Mycobacterium), a time-lapse microscopy-based method that observes individual cells growing into microcolonies. ODELAM enables rapid quantitative measures of growth kinetics in as little as 30 hours under a wide variety of environmental conditions. We demonstrate ODELAM's utility by identifying ofloxacin resistance in cultured clinical isolates of Mtb and benchmark its performance with standard minimum inhibitory concentration (MIC) assays. In Mtb isolate, ODELAM identified ofloxacin heteroresistance and identifies the presence of drug resistant colony forming units (CFUs) at 1 per 1000 CFUs in as little as 48 hours. ODELAM is a powerful new tool that can rapidly evaluate Mtb drug resistance in a laboratory setting.

Data availability

MATLAB data *.mat files and MATLAB *.m files utilized for generating figures in this submission are posted at Dryad. Additional source code has been made available at https://github.com/AitchisonLab/

The following data sets were generated

Article and author information

Author details

  1. Thurston Herricks

    Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0247-7967

  2. Magdalena Donczew

    Department of Microbiology, University of Washington, Seattle, United States
    For correspondence
    mdonczew@uw.edu
    Competing interests
    The authors declare that no competing interests exist.

  3. Fred D Mast

    Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Tige Rustad

    Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Robert Morrison

    Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Timothy R Sterling

    Division of Infectious Disease, Department of Medicine, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. David R Sherman

    Department of Microbiology, University of Washington, Seattle, United States
    For correspondence
    dsherman@uw.edu
    Competing interests
    The authors declare that no competing interests exist.

  8. John D Aitchison

    Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    For correspondence
    John.Aitchison@seattlechildrens.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9153-6497

Funding

National Institutes of Health (U19 AI135976)

  • David R Sherman
  • John D Aitchison

National Institutes of Health (U19 AI111276)

  • John D Aitchison

National Institutes of Health (R01 AI141953)

  • John D Aitchison

National Institutes of Health (P41 GM109824)

  • John D Aitchison

National Institutes of Health (R01 AI063200)

  • Timothy R Sterling

National Institutes of Health (R56 AI118361)

  • Timothy R Sterling

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Herricks et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,222
    views
  • 193
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Thurston Herricks
  2. Magdalena Donczew
  3. Fred D Mast
  4. Tige Rustad
  5. Robert Morrison
  6. Timothy R Sterling
  7. David R Sherman
  8. John D Aitchison
(2020)
ODELAM Rapid sequence-independent detection of drug resistance in isolates of Mycobacterium tuberculosis
eLife 9:e56613.
https://doi.org/10.7554/eLife.56613

Share this article

https://doi.org/10.7554/eLife.56613

Categories and tags

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease

    Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: A genomic epidemiology study

    Gillian AM Tarr, Linda Chui ... Tim A McAllister
    Research Article

    Several areas of the world suffer a notably high incidence of Shiga toxin-producing Escherichia coli. To assess the impact of persistent cross-species transmission systems on the epidemiology of E. coli O157:H7 in Alberta, Canada, we sequenced and assembled E. coli O157:H7 isolates originating from collocated cattle and human populations, 2007–2015. We constructed a timed phylogeny using BEAST2 using a structured coalescent model. We then extended the tree with human isolates through 2019 to assess the long-term disease impact of locally persistent lineages. During 2007–2015, we estimated that 88.5% of human lineages arose from cattle lineages. We identified 11 persistent lineages local to Alberta, which were associated with 38.0% (95% CI 29.3%, 47.3%) of human isolates. During the later period, six locally persistent lineages continued to be associated with human illness, including 74.7% (95% CI 68.3%, 80.3%) of reported cases in 2018 and 2019. Our study identified multiple locally evolving lineages transmitted between cattle and humans persistently associated with E. coli O157:H7 illnesses for up to 13 y. Locally persistent lineages may be a principal cause of the high incidence of E. coli O157:H7 in locations such as Alberta and provide opportunities for focused control efforts.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    MftG is crucial for ethanol metabolism of mycobacteria by linking mycofactocin oxidation to respiration

    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.

    1. Microbiology and Infectious Disease

    Altering the redox status of Chlamydia trachomatis directly impacts its developmental cycle progression

    Vandana Singh, Scot P Ouellette
    Research Article

    Chlamydia trachomatis is an obligate intracellular bacterial pathogen with a unique developmental cycle. It differentiates between two functional and morphological forms: the elementary body (EB) and the reticulate body (RB). The signals that trigger differentiation from one form to the other are unknown. EBs and RBs have distinctive characteristics that distinguish them, including their size, infectivity, proteome, and transcriptome. Intriguingly, they also differ in their overall redox status as EBs are oxidized and RBs are reduced. We hypothesize that alterations in redox may serve as a trigger for secondary differentiation. To test this, we examined the function of the primary antioxidant enzyme alkyl hydroperoxide reductase subunit C (AhpC), a well-known member of the peroxiredoxins family, in chlamydial growth and development. Based on our hypothesis, we predicted that altering the expression of ahpC would modulate chlamydial redox status and trigger earlier or delayed secondary differentiation. Therefore, we created ahpC overexpression and knockdown strains. During ahpC knockdown, ROS levels were elevated, and the bacteria were sensitive to a broad set of peroxide stresses. Interestingly, we observed increased expression of EB-associated genes and concurrent higher production of EBs at an earlier time in the developmental cycle, indicating earlier secondary differentiation occurs under elevated oxidation conditions. In contrast, overexpression of AhpC created a resistant phenotype against oxidizing agents and delayed secondary differentiation. Together, these results indicate that redox potential is a critical factor in developmental cycle progression. For the first time, our study provides a mechanism of chlamydial secondary differentiation dependent on redox status.